Antibody-drug conjugates specifically regulate tumor microenvironment: A promising strategy for pancreatic cancer treatment
{{output}}
Pancreatic cancer, mainly pancreatic ductal adenocarcinoma (PDAC), is aggressive with poor prognosis. Because its clinical manifestations appear at advanced stages, only less than 20 % of patients with PDAC can undergo radical surgery. Chemotherapy, with stron... ...
